Shop CVS Pharmacy for a Cause

The American Cancer Society, CVS Pharmacy, and Johnson & Johnson Consumer Inc. partnership continues to expand in new and different ways, starting with a promotion this June.

From June 18-‍24, when CVS Pharmacy or CVS.com customers purchase NEUTROGENA® or AVEENO® products with SPF 15 or higher (including sun care, facial care, and cosmetics products), Johnson & Johnson Consumer Inc. will contribute $1 to the American Cancer Society, up to $100,000, to help prevent skin cancer. (Trial and travel sizes are excluded from this offer.)

 

Johnson & Johnson Consumer Inc., which owns those two brands, is guaranteeing a donation of at least $25,000.

Aveeno and Neutrogena sunscreens and lotions in a group

CVS Pharmacy announced recently that the drugstore chain will only carry sunscreen products with an SPF of 15 or higher. It also says it will be offering more dermatologist-approved options, along with natural and organic choices. Read more about the CVS Long Live Skin campaign.

The American Cancer Society recommends that people use a broad-spectrum sunscreen with an SPF of 30 or higher. Ideally, about 1 ounce, about a shot glass or palmful, should be used to cover the arms, legs, neck, and face of the average adult. Sunscreen needs to be reapplied at least every two hours to maintain protection.

Tobacco-Free Generation Campus Initiative

Last fall, the Society launched a bold new initiative, the Tobacco-Free Generation Campus Initiative (TFGCI), which will provide grants to accelerate and expand the adoption and implementation of 100% smoke-free and tobacco-free policies on college and university campuses across the nation. The TFGCI initiative, under the direction of the American Cancer Society's Center for Tobacco Control, is supported by the CVS Health Foundation as part of “Be The First,” CVS Health's five-year, $50 million initiative that supports education, advocacy, tobacco control, and healthy behavior programming to help deliver the nation's first tobacco-free generation.

American Cancer Society, CVS Health Foundation, and Center for Tobacco Control Logos

The TFGCI kicked off last fall, awarding grants to 20 colleges and universities that began in October 2016. The second round of grants was awarded to 42 schools and will begin in August 2017. Over the course of three years, the $3.6 million multi-year program will award grants to 125 colleges and universities throughout the U.S. with the greatest need for stronger tobacco prevention and control.

The grants will help schools successfully advocate for, adopt, and implement 100 percent smoke-free and tobacco-free campus policies. Campuses will also receive technical assistance and resources to support their efforts with education, communications, cessation, and evaluation.

A few more rounds of TFGCI grant applications are anticipated before 2019, which will be announced on the Tobacco Free Generation Initiative page.

Of the roughly 20 million college and university students in the U.S., more than one million are projected to die prematurely from cigarette smoking. While approximately 90% of smokers start by age 18, fully 99 % start by age 26, underscoring the importance of supporting those in the young adult age group with more effective prevention and cessation efforts while eliminating exposure to secondhand smoke and all tobacco use in their learning environments.

Focus on the global cancer burden

CVS Health President and CEO, Larry Merlo, and Johnson & Johnson Chairman and CEO, Alex Gorsky, are founding members of the American Cancer Society’s CEOs Against Cancer® Global Council. They join CEOs from Delta, Motorola Solutions, IBM, and other multinational corporations who are united in leading the fight for a world without cancer.

Established in 2017, the CEOs Global Council represents a diversity of thought leadership and expertise, serving in an advisory capacity as partners to help drive mission outcomes, support a culture of health, and sustain impact on reducing the global cancer burden. These executive leaders provide a critical global perspective on how cancer affects business and commerce, employees and their families, and communities around the world.  Their insights help drive the Society’s mission to change the course of cancer today and in the future. Learn more about the Society’s CEOs Against Cancer® Global Council.

Additional involvement

Janssen Pharmaceuticals, owned by Johnson & Johnson, also supports the Society’s Relay For Life and Making Strides Against Breast Cancer program, as well as the Coaches vs. Cancer program in Philadelphia and the Society’s sister advocacy organization, the American Cancer Society Cancer Action Network.

Share this article:

LinkedIn Logo

Twitter button

facebook logo